Press releases and articles

stdClass Object ( [limit] => 3 [order_by] => publish_date [order] => desc [post_types] => Array ( [0] => press-article [1] => press-release ) [template] => press_release [filter_by] => [acf_field] => [tax] => Array ( ) [acf] => )
View all articles

Events

stdClass Object ( [limit] => 3 [order_by] => acf [order] => asc [post_types] => Array ( [0] => event ) [template] => event [filter_by] => [acf_field] => start_date [tax] => Array ( ) [acf] => )
View all events

Blogs and Publications

stdClass Object ( [limit] => 3 [order_by] => publish_date [order] => desc [post_types] => Array ( [0] => post ) [template] => blog [filter_by] => [acf_field] => [tax] => Array ( ) [acf] => )
Artificial Intelligence Lights a Beacon to New Medicine for Neurofibromatosis Type 2
by Ron Alfa
Biology
Empowering host factors to eradicate malaria
by Yolanda Chong
Biology
AI-Enabled Phenotypic Screens Reveal Clinically Relevant Drugs
by Recursion Pharmaceuticals
Biology
View all posts

Press resources

This section provides resources and assets for media partners and journalists looking for background information about Recursion Pharmaceuticals. In this section, you will find corporate descriptions, biographies of our founders, approved images, and logos.  There are many stories to tell about our innovative approach to drug discovery. We welcome you to use this information as a starting point in your story development and reach out to us for interviews and specific details related to your areas of interest.

View our press kit